All News

    HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT

    October 19th 2025, 1:25am

    Article

    Sac-TMT improved progression-free survival in patients with HR+/HER2– breast cancer.

    Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer

    October 19th 2025, 12:28am

    Article

    Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early breast cancer.

    Similar Incidence of Second Primary Tumors After Libtayo or Placebo for CSCC

    October 18th 2025, 11:32pm

    Article

    Postsurgical Libtayo and placebo showed similar rates of second primary tumors in high-risk CSCC

    Enhertu Reduces Risk of Invasive Disease or Death in HER2+ Breast Cancer

    October 18th 2025, 10:49pm

    Article

    Enhertu led to a 53% reduction in the risk of invasive disease or death versus Kadcyla in some patients with high-risk, HER2-positive breast cancer.

    Postsurgical Opdivo Associated With Long-Term Activity in Melanoma

    October 18th 2025, 9:26pm

    Article

    Adjuvant Opdivo significantly extended relapse-free survival in patients with resected stage advanced melanoma.

    Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer

    October 18th 2025, 8:16pm

    Article

    Clinical trial results showed favorable results with Keytruda-based therapy in this ovarian cancer population.

    Imdelltra Improves Survival For Some With Small Cell Lung Cancer

    October 18th 2025, 7:08pm

    Article

    Clinical trial data support the use of Imdelltra as a standard of care for all patients with second-line small cell lung cancer.

    Lymphoma Survivors Find Fatigue Relief From Multidisciplinary Intervention

    October 18th 2025, 6:29pm

    Article

    Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced benefits to fatigue and quality of life.

    Younger Female Patients With Cancer Report Less Emotional Function

    October 18th 2025, 5:46pm

    Article

    Among patients with solid tumors, baseline emotional functioning was moderate, with lower functioning for female and younger patients.

    Imdelltra Plus Chemoimmunotherapy Safely Elicits Responses in ES-SCLC

    October 18th 2025, 4:39pm

    Article

    In patients with extensive-stage small cell lung cancer Imdelltra plus chemoimmunotherapy was associated with positive outcomes.